Wellcome Trust — Full Portfolio

Instacart operates a marketplace connecting grocery retailers with customers who order food and household items for same-day delivery or in-store pickup, serving millions of households across North America through partnerships with over 350 retailers.

ConsumerE-commerceFoodTechSan Francisco, US

AMApoorva Mehta(Chairman \u0026 Founding CEO)inBLBrandon Leonardo(Founder)inMMMax Mullen(Founder)inCRChris Rogers(Chief Executive Officer)inEREmily Reuter(Chief Financial Officer)inHetong Li(Senior Software Engineer)

Co-investorsA*A*ANAndreessen HorowitzAVAvenue Growth PartnersBABACKGROUND CAPITALBLBling CapitalBRBright Pixel Capital+54 more

CorInnova develops a minimally invasive, non-blood contacting cardiac assist device designed to treat acute heart failure patients who cannot use existing solutions.

Deep TechHealthtechMedical DevicesHouston, US

JCJohn Criscione(Director)inWAWilliam Altman(Executive Officer, Director)inDennis Robins(Director)Boris Leschinsky(Executive Officer)Clarice Motter(Executive Officer)Keith Svagerko(Executive Officer)

Co-investorsCOCowtown AngelsHOHouston Angel NetworkKEKeiretsu ForumTMTMC Venture FundHAHarvard Business School Alumni Angels of Greater New YorkAGAggie Angel Network+1 more

Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema.

BiotechDigital HealthHealthtechMedical Devices

OHOlav Hellebø(Chief Executive Officer)in

Co-investorsO2O2h VenturesWRWren CapitalCACambridge Angels groupEMEMV CapitalMAMartlet CapitalSTStoic VC+1 more

Omniox is an IND-stage biotechnology company developing OMX oxygen-delivery vehicles based on its H-NOX platform technology to treat medical conditions where tissue hypoxia drives disease.

BiotechMedical DevicesSan Francisco, US

JWJonathan Winger(Co-Founder & CEO)inStephen Cary(Executive Officer, Director)

BoardJeffrey S. Samberg(Director)LMLaurence Marton(Director)Mitchell Mutz(Director)John Wesley(Director)

Co-investorsECEcoR1 CapitalPLPlug and Play VenturesWAWavemaker Three-Sixty Health

Osivax develops vaccines targeting conserved internal viral structures to provide broader and longer-lasting protection against influenza, leveraging its proprietary oligoDOM technology platform.

BiotechHealthtechMedical DevicesLyon, FR

ALAlexandre Le Vert(Executive Chairman & Co-Founder)inDr Florence Nicolas(Chief Scientific Officer & Co-Founder)DFDr Fergal Hill(Co-founder)

Co-investorsSTStart CapitalCACAP HORN VC

TAE Technologies develops hydrogen-boron (aneutronic) fusion power using a beam-driven Field-Reversed Configuration reactor design, aiming to deliver utility-scale fusion electricity to the grid in the early 2030s.

CleantechDeep TechEnergyFoothill Ranch, US

NRNorman Rostoker(Founder)MBMichl Binderbauer(Founder)inCBCedric Burgher(Chief Financial Officer)in

Co-investorsNENew Enterprise Associates (NEA)CHChevron Technology VenturesCACapital FactoryUPUpVentures CapitalVEVenrockFOFor Good Ventures+1 more

Ineffable is an AI research lab focused on building superintelligence through the reinforcement learning paradigm, emphasizing learning from experience in the environment rather than from human data.

AI & Machine LearningDeep TechLondon, GB

David Silver(Founder)inAlexandre Laterre(Co-Founder)inChris Apps(Founder)in

BoardALAlfred Lin(Director (Sequoia Capital))inRMRavi Mhatre(Director (Lightspeed))in

Co-investorsBOBond Capital ManagementEQEQT VenturesFLFlying Fish VenturesINIndex VenturesLILightspeed Venture PartnersSESequoia Capital+7 more

Karuna Therapeutics is a Boston neuroscience biopharma behind muscarinic drug KarXT, acquired by Bristol Myers Squibb in 2024.

Co-investorsARARCH Venture PartnersPIPivotal Life SciencesSOSofinnova VenturesALAlexandriaPUPureTech Health

BiotechSeattle, US

Shawn Iadonato(Executive Officer, Director)inRobert Hedequist(Executive Officer)Pauline Kenny(Executive Officer)inCharles Magness(Director)

Co-investorsKEKeiretsu ForumPFPfizer Venture InvestmentsTSTSVC

Lumos Pharma is a clinical-stage biopharmaceutical company developing therapies for rare diseases, with a lead candidate targeting Pediatric Growth Hormone Deficiency.

BiotechHealthtechAustin, US

Richard John Hawkins(Executive Officer, Director)John C. McKew(President and Chief Scientific Officer)inP"Pisit "Duke" Pitukcheewanont(Chief Medical Officer)inLLLori Lawley(Chief Financial Officer)inBPBrad Powers(Chief Compliance Officer and General Counsel)inCMCampbell Murray(Executive Chairman)in

Co-investorsNENew Enterprise Associates (NEA)CLClarus VenturesDEDeerfield Management CompanySASante Health VenturesSASante Ventures

Reviral operates an affiliate review site that ranks and reviews online casinos not registered with the UK's GamStop self-exclusion scheme, comparing licences, bonuses, wagering terms, payout speeds, and payment methods.

ConsumerMedia & Entertainment

Co-investorsANAndera PartnersBRBrace PharmaNENew Leaf Venture PartnersOROrbiMed

Subsea and terrestrial optical transport supplier whose assets, rescued by H.I.G. in 2017, are being bought by Prysmian and Fincantieri.

Allen, US

Keith Henderson(Executive Officer)inLes Barkley(Executive Officer)inPaul Colan(Executive Officer)inJon Hopper(Executive Officer, Director)inGary Otake(Executive Officer)inHerve Fevrier(Executive Officer)

Co-investorsARARCH Venture PartnersARAristos VenturesNENew Enterprise Associates (NEA)